• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-365通过靶向ETS1并使AKT/mTOR信号通路失活来抑制肺腺癌的进展。

MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway.

作者信息

Tong L, Han W-Z, Wang J-L, Sun N-N, Zhuang M

机构信息

Department of Respiratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, P.R. China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 May;24(9):4836-4845. doi: 10.26355/eurrev_202005_21172.

DOI:10.26355/eurrev_202005_21172
PMID:32432746
Abstract

OBJECTIVE

MicroRNAs (miRNAs) act as important regulators in human cancers by regulating the gene expression. The dysregulation of miR-365 has been investigated in many cancers. However, the function of miR-365 remains unknown in lung adenocarcinoma. Therefore, the regulatory mechanism of miR-365 was explored in lung adenocarcinoma.

PATIENTS AND METHODS

The expression of miR-365 was detected in cell lines and 67 lung adenocarcinoma tissues using qRT-PCR. The Kaplan-Meier analysis was used to determine the association between miR-365 expressions and the survival rate in patients with lung adenocarcinoma. Transwell assay was then performed to investigate the effect of miR-365 on invasion and migration of lung adenocarcinoma cells.

RESULTS

Downregulation of miR-365 and upregulation of ETS1 were identified in lung adenocarcinoma. Furthermore, miR-365 reversely regulated ETS1 expression in lung adenocarcinoma. Functionally, the overexpression of miR-365 inhibited proliferation, migration, and invasion of lung adenocarcinoma cells. However, the upregulation of ETS1 lessened the inhibitory effect of miR-365 in lung adenocarcinoma. In addition, miR-365 inhibited EMT and inactivated AKT/mTOR pathway in lung adenocarcinoma.

CONCLUSIONS

MiR-365 inhibits the progression of lung adenocarcinoma by targeting ETS1 and inactivating the AKT/mTOR pathway.

摘要

目的

微小RNA(miRNA)通过调控基因表达在人类癌症中发挥重要调节作用。miR-365的失调已在多种癌症中得到研究。然而,miR-365在肺腺癌中的功能仍不清楚。因此,本研究探讨了miR-365在肺腺癌中的调控机制。

患者和方法

采用qRT-PCR检测细胞系和67例肺腺癌组织中miR-365的表达。采用Kaplan-Meier分析确定miR-365表达与肺腺癌患者生存率之间的关系。然后进行Transwell实验以研究miR-365对肺腺癌细胞侵袭和迁移的影响。

结果

在肺腺癌中发现miR-365表达下调,ETS1表达上调。此外,miR-365在肺腺癌中反向调控ETS1的表达。在功能上,miR-365的过表达抑制了肺腺癌细胞的增殖、迁移和侵袭。然而,ETS1的上调减弱了miR-365对肺腺癌的抑制作用。此外,miR-365抑制肺腺癌中的EMT并使AKT/mTOR通路失活。

结论

MiR-365通过靶向ETS1并使AKT/mTOR通路失活来抑制肺腺癌的进展。

相似文献

1
MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway.微小RNA-365通过靶向ETS1并使AKT/mTOR信号通路失活来抑制肺腺癌的进展。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4836-4845. doi: 10.26355/eurrev_202005_21172.
2
MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.miR-129 通过靶向 ETS1 抑制前列腺癌细胞增殖和转移及其对 PI3K/AKT/mTOR 通路的调控
Biomed Pharmacother. 2017 Dec;96:634-641. doi: 10.1016/j.biopha.2017.10.037. Epub 2017 Nov 6.
3
MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.microRNA-381 通过调控 PI3K/Akt 信号通路和上皮间质转化抑制肺腺癌细胞的生物学进展,其直接作用靶点为 LMO3。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8411-8421. doi: 10.26355/eurrev_201910_19152.
4
Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.阻断 VRK2 通过靶向 miR-145-5p 抑制 ERK1/2/AKT 信号通路抑制肺腺癌细胞的进展。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):145-153. doi: 10.26355/eurrev_202101_24378.
5
MicroRNA-149 inhibits the progression of lung adenocarcinoma through targeting RAP1B and inactivating Wnt/β-catenin pathway.微小RNA-149通过靶向RAP1B并使Wnt/β-连环蛋白信号通路失活来抑制肺腺癌的进展。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4846-4854. doi: 10.26355/eurrev_202005_21173.
6
Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.M1 极化巨噬细胞来源的外泌体通过 miR-181a-5p/ETS1/STK16 轴促进肺腺癌细胞凋亡。
Cancer Sci. 2022 Mar;113(3):986-1001. doi: 10.1111/cas.15268. Epub 2022 Jan 28.
7
Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.长链非编码 RNA DUXAP8 的下调通过 TRIM44 介导的 AKT/mTOR 通路调控 miR-498 抑制非小细胞肺癌的增殖、转移和 EMT。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3152-3165. doi: 10.26355/eurrev_202003_20682.
8
LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.长链非编码RNA MALAT1通过靶向miR-206并激活Akt/mTOR信号通路促进非小细胞肺癌的迁移和侵袭。
Anticancer Drugs. 2018 Sep;29(8):725-735. doi: 10.1097/CAD.0000000000000650.
9
Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.突触结合蛋白 12(SYT12)基因表达促进肺腺癌的细胞增殖和进展,并涉及磷酸肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)/雷帕霉素靶蛋白(mTOR)通路。
Med Sci Monit. 2020 Feb 28;26:e920351. doi: 10.12659/MSM.920351.
10
KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.KIF18B 作为微管运动的调节剂,可加速肺腺癌的肿瘤进展并引发不良预后。
Tissue Cell. 2019 Dec;61:44-50. doi: 10.1016/j.tice.2019.09.001. Epub 2019 Sep 3.

引用本文的文献

1
Identification and validation of PSMB7 as a novel biomarker for prognosis and immune infiltrates of lung adenocarcinoma.鉴定和验证PSMB7作为肺腺癌预后和免疫浸润的新型生物标志物。
PeerJ. 2025 Aug 29;13:e19958. doi: 10.7717/peerj.19958. eCollection 2025.
2
MiR-365-3p inhibits lung cancer proliferation and migration via CPT1A-mediated fatty acid oxidation.微小RNA-365-3p通过肉碱棕榈酰转移酶1A介导的脂肪酸氧化抑制肺癌的增殖和迁移。
Sci Rep. 2025 Feb 27;15(1):7076. doi: 10.1038/s41598-025-91665-x.
3
MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways.
微小 RNA 特征可区分乳腺浸润性导管癌 (IDC) 的类型、分级和分期:miRNA-靶相互作用信号通路。
Cell Commun Signal. 2024 Feb 7;22(1):100. doi: 10.1186/s12964-023-01452-2.
4
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.微小RNA对非小细胞肺癌的调控作用及治疗潜力
Heliyon. 2023 Nov 14;9(11):e22080. doi: 10.1016/j.heliyon.2023.e22080. eCollection 2023 Nov.
5
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).微小 RNA 在肺腺癌中的调控作用:信号通路与潜在治疗意义(综述)。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8648. Epub 2023 Oct 20.
6
CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling.环状RNA hsa_circ_0008234通过调控miR-338-3p/ETS1轴和PI3K/AKT/mTOR信号通路促进结肠癌进展。
Cancers (Basel). 2023 Mar 30;15(7):2068. doi: 10.3390/cancers15072068.
7
The Role of MicroRNAs in Pancreatitis Development and Progression.微小 RNA 在胰腺炎发生和进展中的作用。
Int J Mol Sci. 2023 Jan 5;24(2):1057. doi: 10.3390/ijms24021057.
8
Circular RNA circ_0061140 accelerates hypoxia-induced glycolysis, migration, and invasion in lung adenocarcinoma through the microRNA-653/hexokinase 2 (HK2) axis.环状 RNA circ_0061140 通过 microRNA-653/己糖激酶 2(HK2)轴促进肺腺癌缺氧诱导的糖酵解、迁移和侵袭。
Bioengineered. 2022 Mar;13(3):7156-7166. doi: 10.1080/21655979.2021.2000743.
9
Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.环状 RNA-microRNA-mRNA 网络鉴定 circ_0007618 和 circ_0029426 为肺腺癌新的有价值的生物标志物。
Bioengineered. 2022 Mar;13(3):6258-6271. doi: 10.1080/21655979.2022.2027180.
10
microRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions.微小RNA-365通过Toll样受体4介导的干扰素调节因子3磷酸化抑制Yes相关蛋白,从而减轻胃癌前病变。
Cancer Cell Int. 2020 Nov 13;20(1):549. doi: 10.1186/s12935-020-01578-0.